All groups showed a decline in antibody levels from V3 to V4, which was statistically significant in CTRLs and showed a trend in CKD and HD/PD patients, but not in KTRs.
← all excerpts
Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients.
1
—
—